EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Preparation of iodine 125 labeled n pyrazole methylene tetracycline and study of its behavior in the body of intact and tumor bearing animals


Khimiko-Farmatsevticheskii Zhurnal 13(7): 16-20
Preparation of iodine 125 labeled n pyrazole methylene tetracycline and study of its behavior in the body of intact and tumor bearing animals
Preparation of iodine-125 labeled N-C4-pyrazole-methylene-tetracycline and study of its behavior in the body of intact and tumor-bearing animals. N-C4-125I-pyrazole-methylene-tetracycline was synthesized from 125I-pyrazole and tetracycline. Study of the behavior of the obtained preparation in intact and tumor-bearing rats, including data of external radiometry of control and tumor tissue, showed that the maximal level of incorporation of the preparation in the tumor was noted 24 h after administration. The ratio of the specific activity of the portion of the tissue affected by the tumor growth process to that of unaffected tissue was 6 according to data of radiometry bioprobe 24 h after administration, and 5.52 according to data of external radiometry. This preparation may be used for detection of malignant tumors by external radiometry.

(PDF 0-2 workdays service: $29.90)

Accession: 006173354



Related references

Preparation of iodine 125 labeled n c 4 pyrazolylmethyl tetracycline and study of its behavior in the organism of intact and tumor bearing animals. Pharmaceutical Chemistry Journal (English Translation of Khimiko-Farmatsevticheskii Zhurnal) 13(7 PART 1): 686-689, 1979

Preparation of cobalt 57 labeled bleomycetin and study of its kinetics in intact and tumor bearing animals. Khimiko-Farmatsevticheskii Zhurnal 16(6): 660-664, 1982

Production of cobalt 57 labeled bleomycetin and study of its kinetics in the bodies of intact animals and tumor bearing animals. Pharmaceutical Chemistry Journal (English Translation of Khimiko-Farmatsevticheskii Zhurnal) 16(6): 427-431, 1982

Biodistribution of indium 111 and iodine 125 labeled intact ov tl 3 and its fab 2 fragment in tumor bearing mice. European Journal of Nuclear Medicine 16(7): 452, 1990

Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice. Anticancer Research 11(6): 2051-2057, 1991

Preparation and evaluation of iodine 131 tetracycline as a tumor scanning agent part 3 comparison with gallium 67 and various technetium 99m labeled agents. Journal of Nuclear Medicine 16(6): 532, 1975

Pharmaco kinetics of technetium 99m labeled acetyl methionine in the body of tumor bearing animals. Khimiko-Farmatsevticheskii Zhurnal 13(8): 33-35, 1979

A new tumor imaging agent indium 111 labeled bleomycin complex comparison with gallium 67 labeled citrate and cobalt 57 labeled bleomycin in tumor bearing animals. Journal of Surgical Oncology 27(3): 189-195, 1984

Absorption and fate of iodine in iodine 131 labeled soluidine and labeled sodium iodine 131 iodide solution following application to intact human skin. Indian Journal of Pharmacology 12(4): 263-266, 1980

Preparation and evaluation of iodine 131 tetracycline as a tumor scanning agent part 1 preparation and stability. Journal of Nuclear Medicine 16(6): 519, 1975